Pharmanovia has signed a licensing agreement with Lindis Biotech to commercialise catumaxomab, a new trifunctional ...

(BUSINESS WIRE )--Pharmanovia, a global Pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, has today announced the ...

The agreement gives Pharmanovia the exclusive rights to bring to market, catumaxomab, a first-in-class, trifunctional bi-specific monoclonal antibody, indicated for the intraperitoneal treatment of ...

Catumaxomab Received a Positive Opinion From the EMA's Committee for Medicinal Products for Human Use (CHMP) at Its October 2024 Meeting and If ...

Lindis Biotech has licensed Korjuny (catumaxomab) to Pharmanovia for malignant ascites, offering a targeted immune therapy ...

Catumaxomab received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) at its October 2024 meeting and if approved catumaxomab will be the only approved drug for ...

use of an effective diuretic dose.

The nonselective ß-adrenergic blockers (NSBBs) propranolol and nadolol have been the mainstay in the pharmacologic treatment of portal ... do not have refractory ascites. He also suggests that ...

These treatments shrink tumors and limit their spread. Stomach pain Blocked bile ducts, which are the tubes that carry digestive fluids out of the liver Bleeding Ascites, which is fluid buildup in ...

Joseph Ambani, a Medical Doctor at GlowBar, has shared the top symptom for liver cancer which can be spotted during the early ...

The National Comprehensive Cancer Network® (NCCN®)?an alliance of leading cancer centers in the United States?is taking part in the Fourth International Congress of the Asian Oncology Society and the ...

Management typically involves medications that modify the immune system, but natural treatments may also help reduce symptoms. Lupus is an autoimmune condition. It develops when the immune system ...